Robert F. Kennedy Jr. remains the confirmed HHS secretary, with Senate approval in February 2025 and ongoing public actions through mid-2026, including congressional testimony on agency policy and budget matters in April and termination of certain COVID-19 emergency use authorizations in June. Recent reporting has noted internal department tensions and questions about engagement levels, yet no formal resignation announcements, White House signals, or procedural steps toward removal have emerged. Trader consensus on the “No” outcome at 76% aligns with the absence of immediate catalysts that would force an exit before year-end, consistent with typical cabinet tenure patterns absent major scandals or policy reversals. Upcoming legislative sessions and administration priorities could still introduce variables within the resolution window.
Experimental AI-generated summary referencing Polymarket data. This is not trading advice and plays no role in how this market resolves. · Updated$24,291 Vol.
$24,291 Vol.
$24,291 Vol.
$24,291 Vol.
An announcement of Robert F. Kennedy Jr. (RFK Jr.)'s resignation/removal before this market's end date will immediately resolve this market to "Yes", regardless of when the announced resignation/removal goes into effect.
The resolution source for this market will be official information from Robert F. Kennedy Jr. (RFK Jr.) and the U.S. government; however, a consensus of credible reporting may also be used.
Market Opened: Mar 19, 2026, 2:02 PM ET
Resolver
0x65070BE91...An announcement of Robert F. Kennedy Jr. (RFK Jr.)'s resignation/removal before this market's end date will immediately resolve this market to "Yes", regardless of when the announced resignation/removal goes into effect.
The resolution source for this market will be official information from Robert F. Kennedy Jr. (RFK Jr.) and the U.S. government; however, a consensus of credible reporting may also be used.
Resolver
0x65070BE91...Robert F. Kennedy Jr. remains the confirmed HHS secretary, with Senate approval in February 2025 and ongoing public actions through mid-2026, including congressional testimony on agency policy and budget matters in April and termination of certain COVID-19 emergency use authorizations in June. Recent reporting has noted internal department tensions and questions about engagement levels, yet no formal resignation announcements, White House signals, or procedural steps toward removal have emerged. Trader consensus on the “No” outcome at 76% aligns with the absence of immediate catalysts that would force an exit before year-end, consistent with typical cabinet tenure patterns absent major scandals or policy reversals. Upcoming legislative sessions and administration priorities could still introduce variables within the resolution window.
Experimental AI-generated summary referencing Polymarket data. This is not trading advice and plays no role in how this market resolves. · Updated



Beware of external links.
Beware of external links.
Frequently Asked Questions